DIFFERENT ROLES OF D-1 AND D-2 DOPAMINE-RECEPTORS INVOLVED IN LOCOMOTOR-ACTIVITY OF SUPERSENSITIVE MICE

被引：52

作者：

RUBINSTEIN, M ^{[1
]}

GERSHANIK, O ^{[1
]}

STEFANO, FJE ^{[1
]}

机构：

[1] HOSP FRANCES,CTR NEUROL,SECC ENFERMEDADES,BUENOS AIRES,ARGENTINA

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1988年 / 148卷 / 03期

关键词：

D O I：

10.1016/0014-2999(88)90121-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：419 / 426

页数：8

共 25 条

[11] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

LEW, JY ;

ASANO, T ;

ROSENFELD, MR ;

MAKMAN, MH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728

[12]

IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462

[13] MULTIPLE RECEPTORS FOR DOPAMINE [J].

KEBABIAN, JW ;

CALNE, DB .

NATURE, 1979, 277 (5692) :93-96

[14]

LADURON PM, 1983, ACS SYM SER, V224, P22

[15] D-2 DOPAMINE-RECEPTORS ASSOCIATED WITH INHIBITION OF DOPAMINE RELEASE FROM RAT NEOSTRIATUM ARE INDEPENDENT OF CYCLIC-AMP [J].

MEMO, M ;

MISSALE, C ;

CARRUBA, MO ;

SPANO, PF .

NEUROSCIENCE LETTERS, 1986, 71 (02) :192-196

[16] SELECTIVE BLOCKADE OF DOPAMINE D-1 RECEPTORS BY SCH-23390 DISCLOSES STRIATAL DOPAMINE-D-2 RECEPTORS MEDIATING THE INHIBITION OF ADENYLATE-CYCLASE IN RATS [J].

ONALI, P ;

OLIANAS, MC ;

GESSA, GL .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (01) :127-128

[17] SCH 23390 BLOCKS D-1 AND D-2 DOPAMINE-RECEPTORS IN RAT NEOSTRIATUM INVITRO [J].

PLANTJE, JF ;

DAUS, FJ ;

HANSEN, HA ;

STOOF, JC .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (02) :180-182

[18] EFFECTS OF THE PUTATIVE D-1 ANTAGONIST SCH 23390 ON STEREOTYPED BEHAVIOR INDUCED BY THE D-2 AGONIST RU24213 [J].

PUGH, MT ;

OBOYLE, KM ;

MOLLOY, AG ;

WADDINGTON, JL .

PSYCHOPHARMACOLOGY, 1985, 87 (03) :308-312

[19] STIMULATION OF ADENYLATE-CYCLASE IN RAT STRIATUM BY PERGOLIDE - INFLUENCE OF GTP [J].

ROSENFELD, MR ;

MAKMAN, MH ;

GOLDSTEIN, M .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 68 (01) :65-68

[20]

SEEMAN P, 1980, PHARMACOL REV, V32, P229

← 1 2 3 →